It's March 27. On this day in 1998 Viagra made the headlines.

Viagra is more than just a pill. Since its approval in 1998, it has become one of the most iconic pharmaceutical products in modern history — reshaping not only medicine, but culture, business and how we talk about masculinity.

Originally developed by Pfizer as a cardiovascular drug, sildenafil unexpectedly turned into a global breakthrough for treating erectile dysfunction. What followed was a commercial explosion: billions in revenue, worldwide recognition, and a brand so powerful it became part of everyday language.

But the story of Viagra is not just about science. It is about how a medical solution transformed into a cultural phenomenon. It helped break taboos around male sexual health — while also raising new questions about performance pressure, aging, identity and the medicalization of normal life.

Today, the original brand is part of Viatris, while generic versions of sildenafil are produced globally. Yet the legacy remains the same: few drugs have had such a profound impact on both the pharmaceutical industry and society at large.

This is the story of a breakthrough — and the controversy that came with it.

This episode features AI-generated dialogue (NotebookLM), based on extensive research across multiple sources.

It is meant to provide structured context — not replace primary sources or expert analysis.

Hosted on Acast. See acast.com/privacy for more information.